Novartis in Japan
This article was originally published in The Tan Sheet
Executive Summary
Consumer Health division forms joint venture with household products company Kao to introduce OTC brands in Japan. The Novartis Kao portfolio will include new products developed for the Japanese market, international brands suitable for Japan and pharmaceuticals appropriate for switching from Rx status. In January 2001, the Tokyo-based firm will launch an eyecare product for the relief of eyestrain symptoms. Other products will target fatigue, muscle aches and back pain. McNeil Consumer Healthcare recently announced a partnership with Takeda Chemical Industries to launch Tylenol analgesics in Japan (1"The Tan Sheet" July 24, p. 19)
Consumer Health division forms joint venture with household products company Kao to introduce OTC brands in Japan. The Novartis Kao portfolio will include new products developed for the Japanese market, international brands suitable for Japan and pharmaceuticals appropriate for switching from Rx status. In January 2001, the Tokyo-based firm will launch an eyecare product for the relief of eyestrain symptoms. Other products will target fatigue, muscle aches and back pain. McNeil Consumer Healthcare recently announced a partnership with Takeda Chemical Industries to launch Tylenol analgesics in Japan (1 (Also see "McNeil Partnership With Takeda Leads To Tylenol Japan Launch" - Pink Sheet, 24 Jul, 2000.)). |